Skip to main content
main-content

28.04.2016 | Laryngology | Ausgabe 9/2016 Open Access

European Archives of Oto-Rhino-Laryngology 9/2016

Efficacy and tolerability of an ectoine mouth and throat spray compared with those of saline lozenges in the treatment of acute pharyngitis and/or laryngitis: a prospective, controlled, observational clinical trial

Zeitschrift:
European Archives of Oto-Rhino-Laryngology > Ausgabe 9/2016
Autoren:
Dörte Müller, Torben Lindemann, Kija Shah-Hosseini, Olaf Scherner, Markus Knop, Andreas Bilstein, Ralph Mösges
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1007/​s00405-016-4060-z) contains supplementary material, which is available to authorized users.

Abstract

The aim of this observational trial was to evaluate the efficacy and tolerability of a mouth and throat spray containing ectoine in the treatment of acute pharyngitis and/or laryngitis. The outcome was compared with control treatment using saline lozenges. This study was designed as a prospective, controlled, non-randomized, observational multicenter clinical trial and was conducted in Germany. The study population consisted of 95 patients. The decision for treatment with either spray or lozenges was based on the patients’ preference for pharyngeal or oral application. Investigators assessed symptoms specific to acute pharyngitis/laryngitis and determined the pharyngitis symptom score. Both patients and investigators evaluated the tolerability and efficacy of the treatment applied. Treatment with the spray showed higher efficacy, 1.95 ± 0.81 versus 1.68 ± 0.67 (investigators) and 1.97 ± 0.88 versus 1.57 ± 0.69 (patients, p < 0.05). Treatment with the spray resulted in significantly greater reduction of cervical lymph node swelling (p < 0.05), ∆ spray = 0.44 ± 0.62, ∆ lozenges = 0.21 ± 0.62. The lozenges showed some advantage in relieving cough, ∆ lozenges = 0.62 ± 0.94 versus ∆ spray = 0.44 ± 0.85. Both patients and investigators rated the tolerability of both medical devices as “good” to “very good”. Adverse events of mild to moderate severity were either possibly related or not related to the medical devices used. No serious adverse events occurred. Taken together, while the tolerability was consistent in both treatment groups, the ectoine-based spray showed superior efficacy in treating acute pharyngitis and/or laryngitis.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Bis zum 22.10. bestellen und 100 € sparen!

e.Med HNO

Kombi-Abonnement

Mit e.Med HNO erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes HNO, den Premium-Inhalten der HNO-Fachzeitschriften, inklusive einer gedruckten HNO-Zeitschrift Ihrer Wahl.

Nicht verpassen: e.Med bis 22. Oktober 100 € günstiger.

Zusatzmaterial
Supplementary material 1 (DOCX 28 kb)
405_2016_4060_MOESM1_ESM.docx
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 9/2016

European Archives of Oto-Rhino-Laryngology 9/2016 Zur Ausgabe

Neu im Fachgebiet HNO

15.10.2018 | Neues aus der Industrie | Onlineartikel

Rationaler Antibiotikaeinsatz in Klinik und Praxis

11.10.2018 | DAK 2018 | Kongressbericht | Nachrichten

Akupunktur bei allergischen Erkrankungen

11.10.2018 | DAK 2018 | Kongressbericht | Nachrichten

Personalisierte Prävention im Jahr 2030 möglich?

 

 

 
 

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update HNO und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise